|
| |
TOPICS
Animal Welfare
Enforcement
Pharmaceuticals
ANIMAL WELFARE
Global Conference on Animal
Welfare: An OIE Initiative,
http://www.oie.int/eng/Welfare_2004/proceedings.pdf
On 23-25 February 2004 the
OIE organized the first global conference on animal welfare at its headquarters
in Paris.
For more information, see the Q&A and the dedicated OIE website:
http://www.oie.int/eng/Welfare_2004/home.htm
EU Web Page on International
Animal Welfare Issues
http://europa.eu.int/comm/food/animal/welfare/international/index_en.htm
The Meatrix
Make certain your
computer’s sound is on for this link
http://www.themeatrix.com
Animalhandling.org,
American Meat
Institute (AMI), resource for the meat industry, the public and the media about
animal handling in meat plants. www.animalhandling.org
q
Recommended Animal Handling Guidelines and Audit Guide,
Temple Grandin
http://www.animalhandling.org/guidelines/2005RecAnimalHandlingGuidelines.pdf
written by one of the world's leading animal welfare experts, Dr. of Colorado
State University. The guide can be downloaded for free and includes AMI
Foundation audit forms for cattle and calves, pigs and sheep.
ANIMAL RIGHTS vs. ANIMIMAL
WELFARE
-
Animal Rights Versus
Animal Welfare,
Larry Katz, Ph.D., Rutgers Cooperative Extension
http://www.rce.rutgers.edu/pubs/pdfs/fs753.pdf
-
Animal Welfare vs.
Animal Rights,
National Association for Biomedical Research
http://www.fbresearch.org/animal-activism/welfare-vs-rights.htm
-
Concocting New Horrors
in the Animal Kingdom,
James Lilek
http://www.newhouse.com/archive/story1c082102.html
-
Animal Rights
Activists Unleashed,
Steven Milloy,
http://www.foxnews.com/story/0,2933,41281,00.html
-
Animal Welfare is not
Animal Rights!
National Animal Interest Alliance,
http://www.naiaonline.org/body/articles/archives/otherresourcenewkirk.htm
TOP OF PAGE
Rose Acre Farms, Inc. v. United States
- Enforcement action as a takings.
U.S. Court of Appeals for the Federal Circuit (June 30, 2004) No. 03-5103; 2004 U.S. App. LEXIS 13447,
Michel,
Circuit Judge.
“Rose Acre Farms,
Inc. filed the present action in the United States Court of Federal Claims
in 1992, claiming that USDA regulations that restricted egg sales from and
imposed other requirements on farms that tested positive for the presence of
salmonella bacteria effected a taking requiring compensation under the Fifth
Amendment. The trial court held that Rose Acre was entitled to compensation
for a taking of the eggs affected by the regulations, as well as for hens
seized for testing. The court misapplied, however, the standards governing
regulatory takings claims under Penn Central Transportation Co. v. New York
City. In particular, the court incorrectly analyzed the severity of the
economic impact of the regulations and erroneously concluded that the Penn
Central factor pertaining to the character of the government’s actions
favored Rose Acre. The court further erred in concluding that the
regulations effected a per se taking of Rose Acre’s hens. Accordingly, we
vacate and remand for appropriate reconsideration.” [Excerpted from the
opinion (footnotes and citations omitted).
http://fedcir.gov/opinions/03-5103.doc
TOP OF PAGE
PHARMACEUTICALS
F.D.A. Leader Says Study Tied to Vioxx Wasn't Suppressed
GARDINER HARRIS, TIMES NEWS TRACKER (November 18, 2004)
Top federal drug reviewers immediately recognized the importance of a study
showing the cardiovascular risks of the painkiller Vioxx, according to a
statement released yesterday by Dr. Lester M. Crawford, acting commissioner
of the Food and Drug Administration. The drug was withdrawn from the market
by Merck in late September.
http://www.nytimes.com/2004/11/18/business/18hearing.html
FDA Is Flexing Less Muscle: Some Question Its Relationship With Drugmakers
Marc Kaufman and Brooke A. Masters, Washington Post Page A01 (Thursday,
November 18, 2004)
In the past four years, the Food and Drug Administration has taken a
noticeably less aggressive approach toward policing drugs that cause harmful
side effects, records show, leading some lawmakers, academics and consumer
advocates to complain that the agency is focusing more on bolstering the
pharmaceutical industry than protecting public health.
http://www.washingtonpost.com/wp-dyn/articles/A58470-2004Nov17.html
Drug Safety Issues Could Decide New U.S. FDA Head
Mon Nov 15,
2004 03:01 PM ET By Susan Heavey and Lisa Richwine
NEW YORK (Reuters) - An eruption of safety issues over arthritis and
antidepressant drugs on top of a nationwide shortage of flu vaccine
highlights a leadership gap at the top of the U.S. Food and Drug
Administration, analysts and industry experts say. The agency has been run by
an acting commissioner for nearly three of the last four years and seems a
low priority for the Bush administration, these experts said, even though it
regulates products that account for about 25 cents of every dollar Americans
spend annually.
http://www.reuters.com/newsArticle.jhtml?type=topNews&storyID=6818171
FDA announces new initiative to protect the U.S. drug supply through the use
of radiofrequency identification technology
November 15, 2004, FDA Media Release P04-103
The Food and Drug Administration (FDA) today stepped up its efforts to
improve the safety and security of the nation's drug supply through the use
of radio frequency identification (RFID) technology. FDA launched this
effort by publishing a Compliance Policy Guide (CPG) for implementing RFID
feasibility studies and pilot programs that are designed to enhance the
safety and security of the drug supply. This action continues FDA's
commitment to promote the use of RFID by the U.S. drug supply chain by 2007.
http://www.fda.gov:80/bbs/topics/news/2004/NEW01133.html
Merck Faces Proliferating Lawsuits over Vioxx
All Things Considered, November 12, 2004 · Pharmaceutical giant Merck is
braced for a big legal battle over its pain medication Vioxx. The drug was
pulled from the shelves when research showed users were at increased risk of
heart attack. Now, the Vioxx lawsuits are multiplying. Listen at:
http://www.npr.org/templates/story/story.php?storyId=4167677
Cosmetic Ingredient Review (CIR)
http://www.cir-safety.org/findings.shtml The Cosmetic Ingredient Review
(CIR) was established in 1976 by the Cosmetic, Toiletry & Fragrance
Association (CTFA) with support of the U.S. Food & Drug Administration and
the Consumer Federation of America. Although funded by CTFA, CIR and the
review process are independent from CTFA and the cosmetics industry. The
Cosmetic Ingredient Review thoroughly reviews and assesses the safety of
ingredients used in cosmetics in an open, unbiased, and expert manner, and
publishes the results in the open, peer-reviewed scientific literature.
TOP OF PAGE
|
